Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Luca Raess
Observed names:
L. Raess,
Luca Räss
Institution:
Biognosys (Switzerland)
Observed institutions:
ETH Zurich,
Biognosys (Switzerland)
ORCID:
0000-0001-6008-9957
Observed ORCID:
0000-0001-6008-9957
OpenAlex ID:
A5011417620
Size-exclusion chromatography combined with DIA-MS enables deep proteome profiling of extracellular vesicles from melanoma plasma and serum
2024
·
Evelyn Lattmann
, Luca Räss
, et al.
·
Cellular and Molecular Life Sciences
·
24
PDF
A Flexible End-to-End Automated Sample Preparation Workflow Enables Standardized and Scalable Bottom-up Proteomics
2025
·
Sandra Schär
, Luca Räss
, et al.
·
Analytical Chemistry
·
21
Engineered allogeneic T cells decoupling T-cell-receptor and CD3 signalling enhance the antitumour activity of bispecific antibodies
2024
·
Edo Kapetanovic
, Cédric R. Weber
, et al.
·
Nature Biomedical Engineering
·
8
PDF
Enhanced Identifications and Quantification Through Retention Time Down-Sampling in Fast-Cycling Diagonal-PASEF Methods
2025
·
Christopher R. Below
, Oliver M. Bernhardt
, et al.
·
Molecular & Cellular Proteomics
·
7
PDF
Abstract 106: Integrated plasma multi-omics profiling identifies circulating predictive biomarkers and biological pathways associated with treatment response in NSCLC.
2026
·
Laura Heeb
, Polina Shichkova
, et al.
·
Cancer Research
Abstract 3306: Comprehensive plasma profiling in NSCLC patients undergoing IO- and chemotherapy identifies potential proteomic signatures for progression-free survival
2025
·
Angelica Rigutto
, Sandra Schaer
, et al.
·
Cancer Research
Abstract 7238: Quantitative profiling of HLA class I and II antigens and neoantigens in tissue and PBMC samples with an improved mass spectrometry approach
2025
·
Arthur Viodé
, Anamarija Pfeiffer
, et al.
·
Cancer Research
MA09.05 Circulating Protein Signatures and Immune Cells Are Predictive and Prognostic Markers for Patients with NSCLC in the SAKK 17/18 Trial
2024
·
A. Rigutto
, Y. Feng
, et al.
·
Journal of Thoracic Oncology
PDF
39 Leveraging deep proteome profiling of plasma-derived extracellular vesicles for predictive biomarker discovery
2023
·
Evelyn Ruth Lattmann
, Luca Raess
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
150 Class I and II neoantigen mapping in MSI-high colorectal cancer in needle biopsy size tissue samples
2023
·
Ilja E Shapiro
, Luca Raess
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
Abstract 2991: Complementarity of class I and II neoantigen mapping in MSI-high colorectal cancer in needle biopsy size tissue samples
2023
·
Ilja E. Shapiro
, Luca Räss
, et al.
·
Cancer Research
Abstract 4352: Leveraging deep proteome profiling of plasma- and serum-derived extracellular vesicles for melanoma biomarker discovery and disease dissection
2023
·
Evelyn Lattmann
, Luca Räss
, et al.
·
Cancer Research
Abstract 1374: Discovery of MHC class I and class II neoantigens in lung cancer in needle biopsy tissue samples using an optimized high-throughput workflow
2022
·
Ilja E. Shapiro
, Luca Raess
, et al.
·
Cancer Research
Show more works
View as search
Works count:
13
Citation count:
60
H-index:
4
I10-index:
2
Year
Topic
Type